Evidence map›Paper›PMID 34712080›Full record

ArticleSisli Etfal Hastanesi tip bulteni2021

β-Lactam Allergy in Children.

Ayse Suleyman, Ahmet İlhan Yararli, Esra Yucel, Zeynep Tamay, Nermin Guler

Open access · hybridAbstract read
In one paragraph

Article in Sisli Etfal Hastanesi tip bulteni, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ayse SuleymanDepartment of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Ahmet İlhan YararliDepartment of Pediatrics, Elbistan Life Hospital, Kahramanmaras, Turkey.
Esra YucelDepartment of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Zeynep TamayDepartment of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Nermin GulerDepartment of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Istanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveβ-lactam antibiotic allergy is the most common drug allergy in children. Most of the patients with suspected reactions to β-lactam antibiotics can actually tolerate these drugs. The aim of this study is to evaluate clinical and laboratory characteristics of children with β-lactam allergy and to determine cross-reactivity between penicillin and cephalosporins.

methodsThe diagnosis of β-lactam allergy was made based on the results of skin tests and/or drug provocation tests (DPT). Penicillin allergy skin tests were performed with DAP penicillin® (Diater laboratories, Madrid, Spain), penicillin G, and ampicillin/amoxicillin preparations. Skin and provocation tests were performed with the culprit cephalosporin in addition to the penicillin skin and/or provocation tests to evaluate cephalosporin allergy.

resultsWe found that 87.7% (71/81) of patients with β-lactam allergy were able to tolerate the culprit drug. Among ten patients with confirmed diagnosis, two had cross-reactivity (penicillin and cephalosporin) and 8 had a various β-lactam (aminopenicillin

conclusionSkin tests and DPT appear to be useful procedures in the diagnosis, and determination of an alternative safe antibiotic in patients with β-lactam allergy. Most of the patients tolerated the drugs. A minority of the patients with confirmed allergy should avoid all β-lactam antibiotics due to the probability of cross-reactivity.

Indexed as

Beta-lactamscross-reactionsdrug allergyskin tests

Identifiers

PMID34712080
PMCPMC8526219
OpenAlexW3159285651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.